ERBB2 c.2089G>C ;(p.V697L)

Variant ID: 17-37879794-G-C

NM_004448.2(ERBB2):c.2089G>C;(p.V697L)

This variant was identified in 19 publications

View GRCh38 version.




Publications:


Mechanisms of neratinib resistance in HER2-mutant metastatic breast cancer.

Cancer Drug Resistance (Alhambra, Calif.)
Eli, Lisa D LD; Kavuri, Shyam M SM
Publication Date: 2022

Variant appearance in text: HER2: V697L
PubMed Link: 36627899
Variant Present in the following documents:
  • cdr-5-4-873.pdf
View BVdb publication page



Real World Characteristics and Clinical Outcomes of HER2-Mutant Non-Small Cell Lung Cancer Patients Detected by Next-Generation Sequencing.

Cancer Research And Treatment
Ahn, Beung-Chul BC; Han, Ye-Jeong YJ; Kim, Hye Ryun HR; Hong, Min Hee MH; Cho, Byoung Chul BC; Lim, Sun Min SM
Publication Date: 2022-11-09

Variant appearance in text: HER2: V697L
PubMed Link: 36397236
Variant Present in the following documents:
  • crt-2022-359.pdf
View BVdb publication page



Somatic mutation distribution across tumour cohorts provides a signal for positive selection in cancer.

Nature Communications
Boström, Martin M; Larsson, Erik E
Publication Date: 2022-11-17

Variant appearance in text: ERBB2: V697L
PubMed Link: 36396655
Variant Present in the following documents:
  • 41467_2022_34746_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA.

Breast (Edinburgh, Scotland)
Liu, Binliang B; Hu, Zheyu Z; Ran, Jialu J; Xie, Ning N; Tian, Can C; Tang, Yu Y; Ouyang, Quchang Q
Publication Date: 2022-10

Variant appearance in text: ERBB2: V697L
PubMed Link: 35926241
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Integrated DNA and RNA Sequencing Reveals Drivers of Endocrine Resistance in Estrogen Receptor-Positive Breast Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Xia, Youli Y; He, Xiaping X; Renshaw, Lorna L; Martinez-Perez, Carlos C; Kay, Charlene C; Gray, Mark M; Meehan, James J; Parker, Joel S JS; Perou, Charles M CM; Carey, Lisa A LA; Dixon, J Michael JM; Turnbull, Arran A
Publication Date: 2022-08-15

Variant appearance in text: ERBB2: V697L
PubMed Link: 35653148
Variant Present in the following documents:
  • ccr-21-3189_supplementary_tables_ts1-9_suppts1-9.xlsx, sheet 5
View BVdb publication page



Molecular landscape of TP53 mutations in breast cancer and their utility for predicting the response to HER-targeted therapy in HER2 amplification-positive and HER2 mutation-positive amplification-negative patients.

Cancer Medicine
Liu, Binliang B; Yi, Zongbi Z; Guan, Yanfang Y; Ouyang, Quchang Q; Li, Chunxiao C; Guan, Xiuwen X; Lv, Dan D; Li, Lixi L; Zhai, Jingtong J; Qian, Haili H; Xu, Binghe B; Ma, Fei F; Zeng, Yixin Y
Publication Date: 2022-07

Variant appearance in text: ERBB2: 2089G>C; V697L
PubMed Link: 35393784
Variant Present in the following documents:
  • CAM4-11-2767-s001.xlsx, sheet 1
View BVdb publication page



Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.

Cell Reports. Medicine
Hurst, Carolyn D CD; Cheng, Guo G; Platt, Fiona M FM; Castro, Mauro A A MAA; Marzouka, Nour-Al-Dain S NS; Eriksson, Pontus P; Black, Emma V I EVI; Alder, Olivia O; Lawson, Andrew R J ARJ; Lindskrog, Sia V SV; Burns, Julie E JE; Jain, Sunjay S; Roulson, Jo-An JA; Brown, Joanne C JC; Koster, Jan J; Robertson, A Gordon AG; Martincorena, Inigo I; Dyrskjøt, Lars L; Höglund, Mattias M; Knowles, Margaret A MA
Publication Date: 2021-12-21

Variant appearance in text: ERBB2: V697L
PubMed Link: 35028613
Variant Present in the following documents:
  • mmc1.pdf
  • mmc7.pdf
View BVdb publication page



Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications
Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q
Publication Date: 2021-01-04

Variant appearance in text: ERBB2: 2089G>C; V697L
PubMed Link: 33397889
Variant Present in the following documents:
  • 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1
View BVdb publication page



Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer.

Npj Breast Cancer
Yi, Zongbi Z; Rong, Guohua G; Guan, Yanfang Y; Li, Jin J; Chang, Lianpeng L; Li, Hui H; Liu, Binliang B; Wang, Wenna W; Guan, Xiuwen X; Ouyang, Quchang Q; Li, Lixi L; Zhai, Jingtong J; Li, Chunxiao C; Li, Lifeng L; Xia, Xuefeng X; Yang, Ling L; Qian, Haili H; Yi, Xin X; Xu, Binghe B; Ma, Fei F
Publication Date: 2020

Variant appearance in text: ERBB2: 2089G>C; V697L
PubMed Link: 33145402
Variant Present in the following documents:
  • 41523_2020_201_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.

The Lancet. Oncology
Turner, Nicholas C NC; Kingston, Belinda B; Kilburn, Lucy S LS; Kernaghan, Sarah S; Wardley, Andrew M AM; Macpherson, Iain R IR; Baird, Richard D RD; Roylance, Rebecca R; Stephens, Peter P; Oikonomidou, Olga O; Braybrooke, Jeremy P JP; Tuthill, Mark M; Abraham, Jacinta J; Winter, Matthew C MC; Bye, Hannah H; Hubank, Michael M; Gevensleben, Heidrun H; Cutts, Ros R; Snowdon, Claire C; Rea, Daniel D; Cameron, David D; Shaaban, Abeer A; Randle, Katrina K; Martin, Sue S; Wilkinson, Katie K; Moretti, Laura L; Bliss, Judith M JM; Ring, Alistair A
Publication Date: 2020-10

Variant appearance in text: HER2: Val697Leu
PubMed Link: 32919527
Variant Present in the following documents:
  • main.pdf
View BVdb publication page



Phase and context shape the function of composite oncogenic mutations.

Nature
Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS
Publication Date: 2020-06

Variant appearance in text: ERBB2: V697L
PubMed Link: 32461694
Variant Present in the following documents:
  • NIHMS1582596-supplement-1582596_Supp_Tab1-5.xlsx, sheet 2
View BVdb publication page



Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.

Thoracic Cancer
Wei, Xue-Wu XW; Gao, Xin X; Zhang, Xu-Chao XC; Yang, Jin-Ji JJ; Chen, Zhi-Hong ZH; Wu, Yi-Long YL; Zhou, Qing Q
Publication Date: 2020-06

Variant appearance in text: ERBB2: V697L
PubMed Link: 32291971
Variant Present in the following documents:
  • Main text
View BVdb publication page



Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.

Journal Of Oncology
Gaibar, Maria M; Beltrán, Laura L; Romero-Lorca, Alicia A; Fernández-Santander, Ana A; Novillo, Apolonia A
Publication Date: 2020

Variant appearance in text: HER2: V697L
PubMed Link: 32256585
Variant Present in the following documents:
  • Main text
  • JO2020-6375956.pdf
View BVdb publication page



High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features.

Cancers
Rosa-Rosa, Juan Manuel JM; Caniego-Casas, Tamara T; Leskela, Susanna S; Cristobal, Eva E; González-Martínez, Silvia S; Moreno-Moreno, Esther E; López-Miranda, Elena E; Holgado, Esther E; Pérez-Mies, Belén B; Garrido, Pilar P; Palacios, José J
Publication Date: 2019-01-11

Variant appearance in text: ERBB2: V697L
PubMed Link: 30641862
Variant Present in the following documents:
  • Main text
  • cancers-11-00074.pdf
View BVdb publication page



Actionable Activating Oncogenic ERBB2/HER2 Transmembrane and Juxtamembrane Domain Mutations.

Cancer Cell
Pahuja, Kanika Bajaj KB; Nguyen, Thong T TT; Jaiswal, Bijay S BS; Prabhash, Kumar K; Thaker, Tarjani M TM; Senger, Kate K; Chaudhuri, Subhra S; Kljavin, Noelyn M NM; Antony, Aju A; Phalke, Sameer S; Kumar, Prasanna P; Mravic, Marco M; Stawiski, Eric W EW; Vargas, Derek D; Durinck, Steffen S; Gupta, Ravi R; Khanna-Gupta, Arati A; Trabucco, Sally E SE; Sokol, Ethan S ES; Hartmaier, Ryan J RJ; Singh, Ashish A; Chougule, Anuradha A; Trivedi, Vaishakhi V; Dutt, Amit A; Patil, Vijay V; Joshi, Amit A; Noronha, Vanita V; Ziai, James J; Banavali, Sripad D SD; Ramprasad, Vedam V; DeGrado, William F WF; Bueno, Raphael R; Jura, Natalia N; Seshagiri, Somasekar S
Publication Date: 2018-11-12

Variant appearance in text: HER2: V697L
PubMed Link: 30449325
Variant Present in the following documents:
  • Main text
View BVdb publication page



Contribution of allelic imbalance to colorectal cancer.

Nature Communications
Palin, Kimmo K; Pitkänen, Esa E; Turunen, Mikko M; Sahu, Biswajyoti B; Pihlajamaa, Päivi P; Kivioja, Teemu T; Kaasinen, Eevi E; Välimäki, Niko N; Hänninen, Ulrika A UA; Cajuso, Tatiana T; Aavikko, Mervi M; Tuupanen, Sari S; Kilpivaara, Outi O; van den Berg, Linda L; Kondelin, Johanna J; Tanskanen, Tomas T; Katainen, Riku R; Grau, Marta M; Rauanheimo, Heli H; Plaketti, Roosa-Maria RM; Taira, Aurora A; Sulo, Päivi P; Hartonen, Tuomo T; Dave, Kashyap K; Schmierer, Bernhard B; Botla, Sandeep S; Sokolova, Maria M; Vähärautio, Anna A; Gladysz, Kornelia K; Ongen, Halit H; Dermitzakis, Emmanouil E; Bramsen, Jesper Bertram JB; Ørntoft, Torben Falck TF; Andersen, Claus Lindbjerg CL; Ristimäki, Ari A; Lepistö, Anna A; Renkonen-Sinisalo, Laura L; Mecklin, Jukka-Pekka JP; Taipale, Jussi J; Aaltonen, Lauri A LA
Publication Date: 2018-09-10

Variant appearance in text: ERBB2: V697L
PubMed Link: 30202008
Variant Present in the following documents:
  • 41467_2018_6132_MOESM11_ESM.xlsx, sheet 1
View BVdb publication page



Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.

Cell Reports
Way, Gregory P GP; Sanchez-Vega, Francisco F; La, Konnor K; Armenia, Joshua J; Chatila, Walid K WK; Luna, Augustin A; Sander, Chris C; Cherniack, Andrew D AD; Mina, Marco M; Ciriello, Giovanni G; Schultz, Nikolaus N; , ; Sanchez, Yolanda Y; Greene, Casey S CS
Publication Date: 2018-04-03

Variant appearance in text: ERBB2: Val697Leu
PubMed Link: 29617658
Variant Present in the following documents:
  • NIHMS958974-supplement-6.xlsx, sheet 1
View BVdb publication page



Genomic alterations of ERBB receptors in cancer: clinical implications.

Oncotarget
Mishra, Rosalin R; Hanker, Ariella B AB; Garrett, Joan T JT
Publication Date: 2017-12-26

Variant appearance in text: HER2: V697L
PubMed Link: 29371993
Variant Present in the following documents:
  • Main text
  • oncotarget-08-114371.pdf
View BVdb publication page



Clinical and molecular characterization of patients with cancer of unknown primary in the modern era.

Annals Of Oncology : Official Journal Of The European Society For Medical Oncology
Varghese, A M AM; Arora, A A; Capanu, M M; Camacho, N N; Won, H H HH; Zehir, A A; Gao, J J; Chakravarty, D D; Schultz, N N; Klimstra, D S DS; Ladanyi, M M; Hyman, D M DM; Solit, D B DB; Berger, M F MF; Saltz, L B LB
Publication Date: 2017-12-01

Variant appearance in text: ERBB2: V697L
PubMed Link: 29045506
Variant Present in the following documents:
  • Main text
View BVdb publication page